Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
May 03, 2021
We are seeking dedicated members who embody the Board core competencies to lead our organization into the future. If you or a colleague is passionate about endocrine research and medicine and is interested in joining the team who will drive our strategy forward, submit a nomination today.
May 04, 2021
A supplemental issue of the Journal of the Endocrine Society with abstracts from ENDO 2021 is now available! View more than 2,000 abstracts for a recap of the hormone research presented during the meeting.
May 04, 2021
Registration is now open for Clinical Endocrinology Update (CEU) 2021, a virtual meeting taking place September 10-12. CEU 2021 is a comprehensive case-based meeting in which leading experts present the latest advances and critical issues in endocrinology. Register today.
April 30, 2021
Based on the ABIM's blueprint for the Endocrinology, Diabetes, and Metabolism Certification Examination, Endocrine Board Review (EBR) is a virtual case-based course and mock exam reviewing 220 case questions across the breadth of endocrinology. Learn more and register today.
May 06, 2021
We discuss our advocacy for drug pricing legislation, increased telehealth access, and endocrine-disrupting chemical regulation.
Need more info?
Learn more about the advantages of membership
April 22, 2021
The Endocrine Society is calling on Congress to pass legislation to lower the price of insulin and applauds the efforts of Energy and Commerce Committee Chairman Frank Pallone Jr. (D-NJ), Ways and Means Committee Chairman Richard E. Neal (D-MA), and Education and Labor Committee Chairman Robert C. "Bobby" Scott (D-VA) to reintroduce H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, to improve access to affordable medications. In January, the Society published a position statement on insulin access and affordability, which recommends policymakers include government negotiation as part of an overall strategy to reduce insulin prices.
April 14, 2021
The Endocrine Society opposes legislative efforts that do not conform to medical evidence and clinical practice to prevent transgender and gender diverse adolescents from accessing gender-affirming medical care.
April 01, 2021
Endocrine-disrupting chemicals may influence hormonal shifts during pregnancy as well as contribute to postpartum depression, according to a small study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.